Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus. The test follows several case reports in which the drug, ibrutinib, appeared to protect against lung damage and respiratory distress caused by the virus. MedicalXpress
Wednesday, May 20, 2020
Researchers to test blood cancer drug in COVID-19 patients
Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus. The test follows several case reports in which the drug, ibrutinib, appeared to protect against lung damage and respiratory distress caused by the virus. MedicalXpress
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment